These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of camostat, a synthetic protease inhibitor, on endocrine and exocrine pancreas of the rat. Müller MK, Goebell H, Alfen R, Ehlers J, Jäger M, Plümpe H. J Nutr; 1988 May; 118(5):645-50. PubMed ID: 2452864 [Abstract] [Full Text] [Related]
3. Gabexate and camostat, synthetic proteinase inhibitors, as direct inducing factors of water and bicarbonate secretion in the isolated and blood-perfused dog pancreas. Horiuchi A, Iwatsuki K, Yonekura H, Ren LM, Chiba S. J Pharmacol Exp Ther; 1990 Jan; 252(1):320-6. PubMed ID: 1688943 [Abstract] [Full Text] [Related]
4. Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats. Watanabe S, Takeuchi T, Chey WY. Gastroenterology; 1992 Feb; 102(2):621-8. PubMed ID: 1732130 [Abstract] [Full Text] [Related]
9. Elevation of resting fluid secretion precedes trophic responses in the rat pancreas following a single oral administration of Camostat. Terasawa K, Kanno T. Int J Pancreatol; 1991 Apr; 8(3):263-74. PubMed ID: 2051064 [Abstract] [Full Text] [Related]
14. Activation of the mTOR signalling pathway is required for pancreatic growth in protease-inhibitor-fed mice. Crozier SJ, Sans MD, Guo L, D'Alecy LG, Williams JA. J Physiol; 2006 Jun 15; 573(Pt 3):775-86. PubMed ID: 16613881 [Abstract] [Full Text] [Related]
15. Oral administration of sepimostat mesilate prevents acute alcohol pancreatic injury in rats. Yuasa C, Irimura K, Oda M, Fukui K, Oka T. J Pharm Pharmacol; 1999 Jul 15; 51(7):867-71. PubMed ID: 10467964 [Abstract] [Full Text] [Related]
16. Adaptation of pancreatic amino acid transport in rats after treatment with the synthetic protease inhibitor camostat mesilate. Mann GE, Muñoz M. Pancreas; 1989 Jul 15; 4(5):601-5. PubMed ID: 2813329 [Abstract] [Full Text] [Related]
17. Effect of oral administration of protease inhibitor on pancreatic exocrine function in WBN/Kob rats with chronic pancreatitis. Sugiyama M, Kobori O, Atomi Y, Wada N, Kuroda A, Muto T. Pancreas; 1996 Jul 15; 13(1):71-9. PubMed ID: 8783337 [Abstract] [Full Text] [Related]
18. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Niederau C, Liddle RA, Williams JA, Grendell JH. Gut; 1987 Jul 15; 28 Suppl(Suppl):63-9. PubMed ID: 2446964 [Abstract] [Full Text] [Related]
19. CCK-induced pancreatic growth is not limited by mitogenic capacity in mice. Crozier SJ, Sans MD, Lang CH, D'Alecy LG, Ernst SA, Williams JA. Am J Physiol Gastrointest Liver Physiol; 2008 May 15; 294(5):G1148-57. PubMed ID: 18356533 [Abstract] [Full Text] [Related]
20. Subcutaneous administration of the synthetic trypsin inhibitor Foy-305 induces hypertrophy of the exocrine pancreas. Wereszczyńska-Siemiatkowska U, Pohl U, Otto J, Lankisch PG. Digestion; 1987 May 15; 37(3):144-8. PubMed ID: 2443410 [Abstract] [Full Text] [Related] Page: [Next] [New Search]